These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
98 related items for PubMed ID: 17010628
1. Development of acetylated HDD kit for preparation of 188Re-HDD/lipiodol. Lee YS, Jeong JM, Kim YJ, Chang YS, Lee HJ, Son M, Lee JW, Yoon HS, Kang WJ, Lee DS, Chung JK, Lee MC, Suh YG. Appl Radiat Isot; 2007 Jan; 65(1):64-9. PubMed ID: 17010628 [Abstract] [Full Text] [Related]
2. Lipiodol solution of 188Re-HDD as a new therapeutic agent for transhepatic arterial embolization in liver cancer: preclinical study in a rabbit liver cancer model. Paeng JC, Jeong JM, Yoon CJ, Lee YS, Suh YG, Chung JW, Park JH, Chung JK, Son M, Lee MC. J Nucl Med; 2003 Dec; 44(12):2033-8. PubMed ID: 14660730 [Abstract] [Full Text] [Related]
3. Preparation and biodistribution of rhenium-188 ECD/Lipiodol in rats following hepatic arterial injection. Luo TY, Hsieh BT, Wang SJ, Lin WY, Lee TW, Shen LH, Su MJ. Nucl Med Biol; 2004 Jul; 31(5):671-7. PubMed ID: 15219287 [Abstract] [Full Text] [Related]
7. Development of 4-hexadecyl-4,7-diaza-1,10-decanedithiol (HDD) kit for the preparation of the liver cancer therapeutic agent Re-188-HDD/lipiodol. Banka VK, Moon SH, Jeong JM, Seelam SR, Lee YS, Kim YJ, Lee DS, Chung JK. Nucl Med Biol; 2015 Mar; 42(3):317-22. PubMed ID: 25537725 [Abstract] [Full Text] [Related]
8. Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-lipiodol therapy in patients with hepatocellular carcinoma. De Ruyck K, Lambert B, Bacher K, Gemmel F, De Vos F, Vral A, de Ridder L, Dierckx RA, Thierens H. J Nucl Med; 2004 Apr; 45(4):612-8. PubMed ID: 15073257 [Abstract] [Full Text] [Related]
9. Synthesis of 188 Re-labelled long chain alkyl diaminedithiol for therapy of liver cancer. Lee YS, Jeong JM, Kim YJ, Chung JW, Park JH, Suh YG, Lee DS, Chung JK, Lee MC. Nucl Med Commun; 2002 Mar; 23(3):237-42. PubMed ID: 11891481 [Abstract] [Full Text] [Related]
14. Lipiodol solution of a lipophilic agent, (188)Re-TDD, for the treatment of liver cancer. Jeong JM, Kim YJ, Lee YS, Ko JI, Son M, Lee DS, Chung JK, Park JH, Lee MC. Nucl Med Biol; 2001 Feb; 28(2):197-204. PubMed ID: 11295430 [Abstract] [Full Text] [Related]
15. Preparation of 166Ho-oxine-lipiodol and its preliminary bioevaluation for the potential application in therapy of liver cancer. Das T, Chakraborty S, Sarma HD, Venkatesh M, Banerjee S. Nucl Med Commun; 2009 May; 30(5):362-7. PubMed ID: 19282794 [Abstract] [Full Text] [Related]
16. Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin. Moustapha ME, Ehrhardt GJ, Smith CJ, Szajek LP, Eckelman WC, Jurisson SS. Nucl Med Biol; 2006 Jan; 33(1):81-9. PubMed ID: 16459262 [Abstract] [Full Text] [Related]